Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIB Dose Response and Safety Study of Topical Methotrexate Formulations for Fingernail Psoriasis
2006-004346-17Phase 2Terminated
- Sponsor
- MediQuest Therapeutics
- Start
- Mar 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of methotrexate in psoriasis (3 arms), sponsored by MediQuest Therapeutics. Primary endpoint: Primary efficacy: change in target fingernail appearance. Started Mar 2008; status: terminated.
02
Drugs
methotrexate
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2006-004346-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004346-17.